Evidence map›Paper›PMID 32456009›Full record

ArticleBiomolecules2020

Hemp (

Noelia M Rodriguez-Martin, Sergio Montserrat-de la Paz, Rocio Toscano, Elena Grao-Cruces, Alvaro Villanueva, Justo Pedroche, Francisco Millan, Maria C Millan-Linares

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Current and Potential Use of Biologically Active Compounds Derived fromInternational journal of molecular sciences · 2024
    Review
  5. Article
  6. Sacha Inchi (Foods (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Acyclic Diterpene Phytol from Hemp Seed Oil (Foods (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Hempseed (Journal of agricultural and food chemistry · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Noelia M Rodriguez-MartinDepartment of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, Universidad de Sevilla, 41009 Seville, Spain.
Sergio Montserrat-de la PazDepartment of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, Universidad de Sevilla, 41009 Seville, Spain.ORCID 0000-0001-5400-3192
Rocio ToscanoDepartment of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, Universidad de Sevilla, 41009 Seville, Spain.
Elena Grao-CrucesDepartment of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, Universidad de Sevilla, 41009 Seville, Spain.
Alvaro VillanuevaDepartment of Food & Health, Instituto de la Grasa, CSIC, 41013 Seville, Spain.
Justo PedrocheDepartment of Food & Health, Instituto de la Grasa, CSIC, 41013 Seville, Spain.
Francisco MillanDepartment of Food & Health, Instituto de la Grasa, CSIC, 41013 Seville, Spain.ORCID 0000-0001-6309-7629
Maria C Millan-LinaresDepartment of Food & Health, Instituto de la Grasa, CSIC, 41013 Seville, Spain.ORCID 0000-0002-5661-8366
Instituto de la Grasa · ESUniversidad de Sevilla · ES

Funding

CYTED Ciencia y Tecnología para el Desarrollo CYTED-2019 119RT0567
6 · The paper itself

Abstract

Hemp seeds have a wide variety of chemical compounds which present biological activity. Specifically, the focus on proteins and bioactive peptides are increasing as alternative sources of nutraceutical uses. In the literature, hemp protein products (HPPs) have reported antioxidant and anti-inflammatory properties. This study aimed to determine the inflammation-related modulatory effects of HPPs on lipopolysaccharide (LPS)-activated primary human monocytes. CD14

Indexed as

Anti-Inflammatory AgentsCannabisCells, CulturedChemokine CCL2HumansInterleukin-1betaInterleukin-6LipopolysaccharidesMonocytesNitric Oxide Synthase Type IIOrexin ReceptorsPlant ProteinsProtein HydrolysatesReceptors, CCR7Tumor Necrosis Factor-alphaAnti-Inflammatory AgentsCCL2 protein, humanCCR7 protein, humanCD200R1 protein, humanChemokine CCL2Interleukin-1betaInterleukin-6LipopolysaccharidesNitric Oxide Synthase Type IIOrexin ReceptorsPlant ProteinsProtein HydrolysatesReceptors, CCR7Tumor Necrosis Factor-alphahemp seedinflammationmicrogliamonocytespeptidespolarizationprotein hydrolysates

Identifiers

PMID32456009
PMCPMC7277103
OpenAlexW3028544120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.